Cargando…

Programmatic Evaluation of a Combined Antigen and Antibody Test for Rapid HIV Diagnosis in a Community and Sexual Health Clinic Screening Programme

BACKGROUND: A substantial proportion of HIV-infected individuals in the UK are unaware of their status and late presentations continue, especially in low prevalence areas. Fourth generation antigen/antibody rapid test kits could facilitate earlier diagnosis of HIV in non-clinical settings but lack d...

Descripción completa

Detalles Bibliográficos
Autores principales: Taegtmeyer, Miriam, MacPherson, Peter, Jones, Kathy, Hopkins, Mark, Moorcroft, Jay, Lalloo, David G., Chawla, Anu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222669/
https://www.ncbi.nlm.nih.gov/pubmed/22132195
http://dx.doi.org/10.1371/journal.pone.0028019
_version_ 1782217217536950272
author Taegtmeyer, Miriam
MacPherson, Peter
Jones, Kathy
Hopkins, Mark
Moorcroft, Jay
Lalloo, David G.
Chawla, Anu
author_facet Taegtmeyer, Miriam
MacPherson, Peter
Jones, Kathy
Hopkins, Mark
Moorcroft, Jay
Lalloo, David G.
Chawla, Anu
author_sort Taegtmeyer, Miriam
collection PubMed
description BACKGROUND: A substantial proportion of HIV-infected individuals in the UK are unaware of their status and late presentations continue, especially in low prevalence areas. Fourth generation antigen/antibody rapid test kits could facilitate earlier diagnosis of HIV in non-clinical settings but lack data on performance under programmatic conditions. METHODS AND FINDINGS: We evaluated the performance of Determine HIV-1/2 Ag/Ab Combo Test (Determine Combo), a rapid test with indicators for both HIV antibodies and p24 antigen, in participants recruited from community outreach and hospital-based sexual health clinics. HIV infection was confirmed using laboratory enzyme-linked immunosorbent assay (EIA), Line Immuno Assay (LIA) and quantitative polymerase chain reaction (PCR). In total, 953 people underwent HIV testing. HIV antibody (Ab) prevalence was 1.8% (17/953). Four false positive rapid tests were identified: two antibody and two p24 antigen (Ag) reactions. Of participants diagnosed as HIV Ab positive, 2/17 (12%) were recent seroconverters based on clinical history and HIV antibody avidity test results. However, none of these were detected by the p24 antigen component of the rapid test kit. There were no other true positive p24 Ag tests. CONCLUSION: These data lend support to an increasing body of evidence suggesting that 4th generation rapid HIV tests have little additional benefit over 3rd generation HIV kits for routine screening in low prevalence settings and have high rates of false positives. In order to optimally combine community-based case-finding among hard-to-reach groups with reliable and early diagnosis 3rd generation kits should be primarily used with laboratory testing of individuals thought to be at risk of acute HIV infection. A more reliable point of care diagnostic is required for the accurate detection of acute HIV infection under programmatic conditions.
format Online
Article
Text
id pubmed-3222669
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-32226692011-11-30 Programmatic Evaluation of a Combined Antigen and Antibody Test for Rapid HIV Diagnosis in a Community and Sexual Health Clinic Screening Programme Taegtmeyer, Miriam MacPherson, Peter Jones, Kathy Hopkins, Mark Moorcroft, Jay Lalloo, David G. Chawla, Anu PLoS One Research Article BACKGROUND: A substantial proportion of HIV-infected individuals in the UK are unaware of their status and late presentations continue, especially in low prevalence areas. Fourth generation antigen/antibody rapid test kits could facilitate earlier diagnosis of HIV in non-clinical settings but lack data on performance under programmatic conditions. METHODS AND FINDINGS: We evaluated the performance of Determine HIV-1/2 Ag/Ab Combo Test (Determine Combo), a rapid test with indicators for both HIV antibodies and p24 antigen, in participants recruited from community outreach and hospital-based sexual health clinics. HIV infection was confirmed using laboratory enzyme-linked immunosorbent assay (EIA), Line Immuno Assay (LIA) and quantitative polymerase chain reaction (PCR). In total, 953 people underwent HIV testing. HIV antibody (Ab) prevalence was 1.8% (17/953). Four false positive rapid tests were identified: two antibody and two p24 antigen (Ag) reactions. Of participants diagnosed as HIV Ab positive, 2/17 (12%) were recent seroconverters based on clinical history and HIV antibody avidity test results. However, none of these were detected by the p24 antigen component of the rapid test kit. There were no other true positive p24 Ag tests. CONCLUSION: These data lend support to an increasing body of evidence suggesting that 4th generation rapid HIV tests have little additional benefit over 3rd generation HIV kits for routine screening in low prevalence settings and have high rates of false positives. In order to optimally combine community-based case-finding among hard-to-reach groups with reliable and early diagnosis 3rd generation kits should be primarily used with laboratory testing of individuals thought to be at risk of acute HIV infection. A more reliable point of care diagnostic is required for the accurate detection of acute HIV infection under programmatic conditions. Public Library of Science 2011-11-22 /pmc/articles/PMC3222669/ /pubmed/22132195 http://dx.doi.org/10.1371/journal.pone.0028019 Text en Taegtmeyer et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Taegtmeyer, Miriam
MacPherson, Peter
Jones, Kathy
Hopkins, Mark
Moorcroft, Jay
Lalloo, David G.
Chawla, Anu
Programmatic Evaluation of a Combined Antigen and Antibody Test for Rapid HIV Diagnosis in a Community and Sexual Health Clinic Screening Programme
title Programmatic Evaluation of a Combined Antigen and Antibody Test for Rapid HIV Diagnosis in a Community and Sexual Health Clinic Screening Programme
title_full Programmatic Evaluation of a Combined Antigen and Antibody Test for Rapid HIV Diagnosis in a Community and Sexual Health Clinic Screening Programme
title_fullStr Programmatic Evaluation of a Combined Antigen and Antibody Test for Rapid HIV Diagnosis in a Community and Sexual Health Clinic Screening Programme
title_full_unstemmed Programmatic Evaluation of a Combined Antigen and Antibody Test for Rapid HIV Diagnosis in a Community and Sexual Health Clinic Screening Programme
title_short Programmatic Evaluation of a Combined Antigen and Antibody Test for Rapid HIV Diagnosis in a Community and Sexual Health Clinic Screening Programme
title_sort programmatic evaluation of a combined antigen and antibody test for rapid hiv diagnosis in a community and sexual health clinic screening programme
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222669/
https://www.ncbi.nlm.nih.gov/pubmed/22132195
http://dx.doi.org/10.1371/journal.pone.0028019
work_keys_str_mv AT taegtmeyermiriam programmaticevaluationofacombinedantigenandantibodytestforrapidhivdiagnosisinacommunityandsexualhealthclinicscreeningprogramme
AT macphersonpeter programmaticevaluationofacombinedantigenandantibodytestforrapidhivdiagnosisinacommunityandsexualhealthclinicscreeningprogramme
AT joneskathy programmaticevaluationofacombinedantigenandantibodytestforrapidhivdiagnosisinacommunityandsexualhealthclinicscreeningprogramme
AT hopkinsmark programmaticevaluationofacombinedantigenandantibodytestforrapidhivdiagnosisinacommunityandsexualhealthclinicscreeningprogramme
AT moorcroftjay programmaticevaluationofacombinedantigenandantibodytestforrapidhivdiagnosisinacommunityandsexualhealthclinicscreeningprogramme
AT lalloodavidg programmaticevaluationofacombinedantigenandantibodytestforrapidhivdiagnosisinacommunityandsexualhealthclinicscreeningprogramme
AT chawlaanu programmaticevaluationofacombinedantigenandantibodytestforrapidhivdiagnosisinacommunityandsexualhealthclinicscreeningprogramme